[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific RNAi for Therapeutic Market Report 2017

December 2017 | 111 pages | ID: A959FAB3CDCEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific RNAi for Therapeutic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of RNAi for Therapeutic for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific RNAi for Therapeutic market competition by top manufacturers/players, with RNAi for Therapeutic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Alnylam Pharmaceuticals
  • Arbutus Biopharma (Tekmira)
  • Arrowhead Research
  • Dicerna Pharmaceuticals
  • Mirna Therapeutics
  • Quark Pharmaceuticals
  • RXi Pharmaceuticals
  • Silence Therapeutics
  • Benitec Biopharma
  • Miragen Therapeutics
  • Sylentis
  • Gradalis
  • Sirnaomics
  • Silenseed
  • Arcturus Therapeutics
  • Ariz Biopharma
  • Celsion Corporation
  • Ascletis Pharmaceuticals
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • siRNA
  • miRNA
  • shRNA
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Cancer
  • Cardiovascular
  • HBV
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific RNAi for Therapeutic Market Report 2017

1 RNAI FOR THERAPEUTIC OVERVIEW

1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 Classification of RNAi for Therapeutic by Product Category
  1.2.1 Asia-Pacific RNAi for Therapeutic Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific RNAi for Therapeutic Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 siRNA
  1.2.4 miRNA
  1.2.5 shRNA
1.3 Asia-Pacific RNAi for Therapeutic Market by Application/End Users
  1.3.1 Asia-Pacific RNAi for Therapeutic Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Cancer
  1.3.3 Cardiovascular
  1.3.4 HBV
  1.3.5 Other
1.4 Asia-Pacific RNAi for Therapeutic Market by Region
  1.4.1 Asia-Pacific RNAi for Therapeutic Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of RNAi for Therapeutic (2012-2022)
  1.5.1 Asia-Pacific RNAi for Therapeutic Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC RNAI FOR THERAPEUTIC COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific RNAi for Therapeutic Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific RNAi for Therapeutic Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific RNAi for Therapeutic Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific RNAi for Therapeutic (Volume and Value) by Type
  2.2.1 Asia-Pacific RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific RNAi for Therapeutic (Volume) by Application
2.4 Asia-Pacific RNAi for Therapeutic (Volume and Value) by Region
  2.4.1 Asia-Pacific RNAi for Therapeutic Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific RNAi for Therapeutic Revenue and Market Share by Region (2012-2017)

3 CHINA RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

3.1 China RNAi for Therapeutic Sales and Value (2012-2017)
  3.1.1 China RNAi for Therapeutic Sales Volume and Growth Rate (2012-2017)
  3.1.2 China RNAi for Therapeutic Revenue and Growth Rate (2012-2017)
  3.1.3 China RNAi for Therapeutic Sales Price Trend (2012-2017)
3.2 China RNAi for Therapeutic Sales Volume and Market Share by Type
3.3 China RNAi for Therapeutic Sales Volume and Market Share by Application

4 JAPAN RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

4.1 Japan RNAi for Therapeutic Sales and Value (2012-2017)
  4.1.1 Japan RNAi for Therapeutic Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan RNAi for Therapeutic Revenue and Growth Rate (2012-2017)
  4.1.3 Japan RNAi for Therapeutic Sales Price Trend (2012-2017)
4.2 Japan RNAi for Therapeutic Sales Volume and Market Share by Type
4.3 Japan RNAi for Therapeutic Sales Volume and Market Share by Application

5 SOUTH KOREA RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea RNAi for Therapeutic Sales and Value (2012-2017)
  5.1.1 South Korea RNAi for Therapeutic Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea RNAi for Therapeutic Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea RNAi for Therapeutic Sales Price Trend (2012-2017)
5.2 South Korea RNAi for Therapeutic Sales Volume and Market Share by Type
5.3 South Korea RNAi for Therapeutic Sales Volume and Market Share by Application

6 TAIWAN RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan RNAi for Therapeutic Sales and Value (2012-2017)
  6.1.1 Taiwan RNAi for Therapeutic Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan RNAi for Therapeutic Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan RNAi for Therapeutic Sales Price Trend (2012-2017)
6.2 Taiwan RNAi for Therapeutic Sales Volume and Market Share by Type
6.3 Taiwan RNAi for Therapeutic Sales Volume and Market Share by Application

7 INDIA RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

7.1 India RNAi for Therapeutic Sales and Value (2012-2017)
  7.1.1 India RNAi for Therapeutic Sales Volume and Growth Rate (2012-2017)
  7.1.2 India RNAi for Therapeutic Revenue and Growth Rate (2012-2017)
  7.1.3 India RNAi for Therapeutic Sales Price Trend (2012-2017)
7.2 India RNAi for Therapeutic Sales Volume and Market Share by Type
7.3 India RNAi for Therapeutic Sales Volume and Market Share by Application

8 SOUTHEAST ASIA RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia RNAi for Therapeutic Sales and Value (2012-2017)
  8.1.1 Southeast Asia RNAi for Therapeutic Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia RNAi for Therapeutic Sales Price Trend (2012-2017)
8.2 Southeast Asia RNAi for Therapeutic Sales Volume and Market Share by Type
8.3 Southeast Asia RNAi for Therapeutic Sales Volume and Market Share by Application

9 AUSTRALIA RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

9.1 Australia RNAi for Therapeutic Sales and Value (2012-2017)
  9.1.1 Australia RNAi for Therapeutic Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia RNAi for Therapeutic Revenue and Growth Rate (2012-2017)
  9.1.3 Australia RNAi for Therapeutic Sales Price Trend (2012-2017)
9.2 Australia RNAi for Therapeutic Sales Volume and Market Share by Type
9.3 Australia RNAi for Therapeutic Sales Volume and Market Share by Application

10 ASIA-PACIFIC RNAI FOR THERAPEUTIC PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Alnylam Pharmaceuticals
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 RNAi for Therapeutic Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Arbutus Biopharma (Tekmira)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 RNAi for Therapeutic Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Arrowhead Research
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 RNAi for Therapeutic Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Arrowhead Research RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Dicerna Pharmaceuticals
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 RNAi for Therapeutic Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Mirna Therapeutics
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 RNAi for Therapeutic Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Quark Pharmaceuticals
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 RNAi for Therapeutic Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 RXi Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 RNAi for Therapeutic Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Silence Therapeutics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 RNAi for Therapeutic Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Silence Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Benitec Biopharma
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 RNAi for Therapeutic Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Benitec Biopharma RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Miragen Therapeutics
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 RNAi for Therapeutic Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Miragen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Sylentis
10.12 Gradalis
10.13 Sirnaomics
10.14 Silenseed
10.15 Arcturus Therapeutics
10.16 Ariz Biopharma
10.17 Celsion Corporation
10.18 Ascletis Pharmaceuticals

11 RNAI FOR THERAPEUTIC MANUFACTURING COST ANALYSIS

11.1 RNAi for Therapeutic Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of RNAi for Therapeutic

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 RNAi for Therapeutic Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC RNAI FOR THERAPEUTIC MARKET FORECAST (2017-2022)

15.1 Asia-Pacific RNAi for Therapeutic Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific RNAi for Therapeutic Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific RNAi for Therapeutic Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific RNAi for Therapeutic Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific RNAi for Therapeutic Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific RNAi for Therapeutic Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific RNAi for Therapeutic Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific RNAi for Therapeutic Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific RNAi for Therapeutic Price Forecast by Type (2017-2022)
15.4 Asia-Pacific RNAi for Therapeutic Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of RNAi for Therapeutic
Figure Asia-Pacific RNAi for Therapeutic Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific RNAi for Therapeutic Sales Volume Market Share by Type (Product Category) in 2016
Figure siRNA Product Picture
Figure miRNA Product Picture
Figure shRNA Product Picture
Figure Asia-Pacific RNAi for Therapeutic Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of RNAi for Therapeutic by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure HBV Examples
Table Key Downstream Customer in HBV
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific RNAi for Therapeutic Market Size (Million USD) by Region (2012-2022)
Figure China RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure India RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific RNAi for Therapeutic Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific RNAi for Therapeutic Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific RNAi for Therapeutic Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific RNAi for Therapeutic Sales Share by Players/Suppliers
Figure Asia-Pacific RNAi for Therapeutic Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific RNAi for Therapeutic Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific RNAi for Therapeutic Revenue Share by Players
Figure 2017 Asia-Pacific RNAi for Therapeutic Revenue Share by Players
Table Asia-Pacific RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales Share by Type (2012-2017)
Figure Sales Market Share of RNAi for Therapeutic by Type (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNAi for Therapeutic by Type (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales Share by Region (2012-2017)
Figure Sales Market Share of RNAi for Therapeutic by Region (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Region in 2016
Table Asia-Pacific RNAi for Therapeutic Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of RNAi for Therapeutic by Region (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share by Region in 2016
Table Asia-Pacific RNAi for Therapeutic Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure China RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure China RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Figure China RNAi for Therapeutic Sales Price (USD/Unit) Trend (2012-2017)
Table China RNAi for Therapeutic Sales Volume (K Units) by Type (2012-2017)
Table China RNAi for Therapeutic Sales Volume Market Share by Type (2012-2017)
Figure China RNAi for Therapeutic Sales Volume Market Share by Type in 2016
Table China RNAi for Therapeutic Sales Volume (K Units) by Applications (2012-2017)
Table China RNAi for Therapeutic Sales Volume Market Share by Application (2012-2017)
Figure China RNAi for Therapeutic Sales Volume Market Share by Application in 2016
Figure Japan RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Japan RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan RNAi for Therapeutic Sales Price (USD/Unit) Trend (2012-2017)
Table Japan RNAi for Therapeutic Sales Volume (K Units) by Type (2012-2017)
Table Japan RNAi for Therapeutic Sales Volume Market Share by Type (2012-2017)
Figure Japan RNAi for Therapeutic Sales Volume Market Share by Type in 2016
Table Japan RNAi for Therapeutic Sales Volume (K Units) by Applications (2012-2017)
Table Japan RNAi for Therapeutic Sales Volume Market Share by Application (2012-2017)
Figure Japan RNAi for Therapeutic Sales Volume Market Share by Application in 2016
Figure South Korea RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea RNAi for Therapeutic Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea RNAi for Therapeutic Sales Volume (K Units) by Type (2012-2017)
Table South Korea RNAi for Therapeutic Sales Volume Market Share by Type (2012-2017)
Figure South Korea RNAi for Therapeutic Sales Volume Market Share by Type in 2016
Table South Korea RNAi for Therapeutic Sales Volume (K Units) by Applications (2012-2017)
Table South Korea RNAi for Therapeutic Sales Volume Market Share by Application (2012-2017)
Figure South Korea RNAi for Therapeutic Sales Volume Market Share by Application in 2016
Figure Taiwan RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan RNAi for Therapeutic Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan RNAi for Therapeutic Sales Volume (K Units) by Type (2012-2017)
Table Taiwan RNAi for Therapeutic Sales Volume Market Share by Type (2012-2017)
Figure Taiwan RNAi for Therapeutic Sales Volume Market Share by Type in 2016
Table Taiwan RNAi for Therapeutic Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan RNAi for Therapeutic Sales Volume Market Share by Application (2012-2017)
Figure Taiwan RNAi for Therapeutic Sales Volume Market Share by Application in 2016
Figure India RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure India RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Figure India RNAi for Therapeutic Sales Price (USD/Unit) Trend (2012-2017)
Table India RNAi for Therapeutic Sales Volume (K Units) by Type (2012-2017)
Table India RNAi for Therapeutic Sales Volume Market Share by Type (2012-2017)
Figure India RNAi for Therapeutic Sales Volume Market Share by Type in 2016
Table India RNAi for Therapeutic Sales Volume (K Units) by Application (2012-2017)
Table India RNAi for Therapeutic Sales Volume Market Share by Application (2012-2017)
Figure India RNAi for Therapeutic Sales Volume Market Share by Application in 2016
Figure Southeast Asia RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia RNAi for Therapeutic Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia RNAi for Therapeutic Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia RNAi for Therapeutic Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia RNAi for Therapeutic Sales Volume Market Share by Type in 2016
Table Southeast Asia RNAi for Therapeutic Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia RNAi for Therapeutic Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia RNAi for Therapeutic Sales Volume Market Share by Application in 2016
Figure Australia RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Australia RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia RNAi for Therapeutic Sales Price (USD/Unit) Trend (2012-2017)
Table Australia RNAi for Therapeutic Sales Volume (K Units) by Type (2012-2017)
Table Australia RNAi for Therapeutic Sales Volume Market Share by Type (2012-2017)
Figure Australia RNAi for Therapeutic Sales Volume Market Share by Type in 2016
Table Australia RNAi for Therapeutic Sales Volume (K Units) by Applications (2012-2017)
Table Australia RNAi for Therapeutic Sales Volume Market Share by Application (2012-2017)
Figure Australia RNAi for Therapeutic Sales Volume Market Share by Application in 2016
Table Alnylam Pharmaceuticals RNAi for Therapeutic Basic Information List
Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Basic Information List
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table Arrowhead Research RNAi for Therapeutic Basic Information List
Table Arrowhead Research RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Research RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Arrowhead Research RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure Arrowhead Research RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table Dicerna Pharmaceuticals RNAi for Therapeutic Basic Information List
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table Mirna Therapeutics RNAi for Therapeutic Basic Information List
Table Mirna Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mirna Therapeutics RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Mirna Therapeutics RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure Mirna Therapeutics RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table Quark Pharmaceuticals RNAi for Therapeutic Basic Information List
Table Quark Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark Pharmaceuticals RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Quark Pharmaceuticals RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure Quark Pharmaceuticals RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table RXi Pharmaceuticals RNAi for Therapeutic Basic Information List
Table RXi Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure RXi Pharmaceuticals RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure RXi Pharmaceuticals RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure RXi Pharmaceuticals RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table Silence Therapeutics RNAi for Therapeutic Basic Information List
Table Silence Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Silence Therapeutics RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Silence Therapeutics RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure Silence Therapeutics RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table Benitec Biopharma RNAi for Therapeutic Basic Information List
Table Benitec Biopharma RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Benitec Biopharma RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure Benitec Biopharma RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table Miragen Therapeutics RNAi for Therapeutic Basic Information List
Table Miragen Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Miragen Therapeutics RNAi for Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Miragen Therapeutics RNAi for Therapeutic Sales Market Share in Asia-Pacific (2012-2017)
Figure Miragen Therapeutics RNAi for Therapeutic Revenue Market Share in Asia-Pacific (2012-2017)
Table Sylentis RNAi for Therapeutic Basic Information List
Table Gradalis RNAi for Therapeutic Basic Information List
Table Sirnaomics RNAi for Therapeutic Basic Information List
Table Silenseed RNAi for Therapeutic Basic Information List
Table Arcturus Therapeutics RNAi for Therapeutic Basic Information List
Table Ariz Biopharma RNAi for Therapeutic Basic Information List
Table Celsion Corporation RNAi for Therapeutic Basic Information List
Table Ascletis Pharmaceuticals RNAi for Therapeutic Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNAi for Therapeutic
Figure Manufacturing Process Analysis of RNAi for Therapeutic
Figure RNAi for Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2016
Table Major Buyers of RNAi for Therapeutic
Table Distributors/Traders List
Figure Asia-Pacific RNAi for Therapeutic Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific RNAi for Therapeutic Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific RNAi for Therapeutic Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific RNAi for Therapeutic Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific RNAi for Therapeutic Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific RNAi for Therapeutic Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share Forecast by Region in 2022
Figure China RNAi for Therapeutic Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan RNAi for Therapeutic Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea RNAi for Therapeutic Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan RNAi for Therapeutic Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India RNAi for Therapeutic Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNAi for Therapeutic Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia RNAi for Therapeutic Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific RNAi for Therapeutic Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific RNAi for Therapeutic Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific RNAi for Therapeutic Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific RNAi for Therapeutic Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories